NewsPoliticsEntertainmentSportsHealth & LifestyleEconomy

VGGS 2024: Gujarat's CM Shri Bhupendrabhai Patel to grace Pre-Summit on January 5

Ahead of the upcoming 10th Vibrant Gujarat Global Summit, the Department of Health and Family Welfare has organized a pre-summit on 'Holistic Healthcare: Good Health and Well Being for All' on Friday, 5 January 2024 at The Leela Hotel, Gandhinagar....
08:15 PM Jan 03, 2024 IST | Aakash Khuman
Gujarat

Ahead of the upcoming 10th Vibrant Gujarat Global Summit, the Department of Health and Family Welfare has organized a pre-summit on 'Holistic Healthcare: Good Health and Well Being for All' on Friday, 5 January 2024 at The Leela Hotel, Gandhinagar. The program will be attended by senior government officials, industry experts and various stakeholders. The program will focus on topics such as promoting the pharmaceuticals and medical devices sector as well as leveraging technology to transform the healthcare sector and promote universal healthcare.

Also Read: Adani Total Gas and Shigan Ink MoU for Decarbonisation Initiatives

The program will begin with the inaugural session, in which Hon'ble Chief Minister of Gujarat Shri Bhupendrabhai Patel, Hon'ble Cabinet Minister of Health and Family Welfare, Government of Gujarat Shri Rushikeshbhai Patel, Principal Secretary of Health and Family Welfare, Government of Gujarat Shri Dhananjay Dwivedi and Commissioner and Secretary of Health Department, Government of Gujarat Shri. Harshad Patel will attend.

Three plenary sessions will be held in this program.

The first plenary session will be held on the topic of Promoting Pharmaceuticals and Medical Devices Sector. The session will bring together industry experts on a platform to deliberate on API and production linked incentive schemes, bulk drug and medical devices parks and strategies to promote these sectors and expand the healthcare ecosystem. The session was moderated by Dr. Chief, Corporate Affairs and Strategic Advisor, Zydus Life Sciences. Sunil Parekh, and its panelists included Mr. Ravindra Pratap Singh, Joint Secretary, Department of Pharmaceuticals, Government of India, Country Director, US FDA, Dr. Dr. Sarah McMullan, IDMA National President. Viranchi Shah, Mr. Sudhir Vaidh, Chairman, Concord Biotech Ltd. and Mr. Vivek Shah, CEO, Merrill Lifesciences Pvt.

The second plenary session will be on Technology Transforming Healthcare, which will discuss government initiatives to leverage technology to strengthen healthcare as well as various innovations and technological developments that are improving healthcare. The session will be chaired and moderated by Shri Harshad Patel, Secretary Public Health and Health Commissioner, Government of Gujarat. Among the panelists of this session Prof. Director of Instem, Department of Biotechnology, Government of India. Dr. Manisha Inamdar, Associate Director, C-DAC, MeitY, Government of India. Sanjay Sood, Vice President & Managing Director, Medtronics India, Mr. Michael Blackwell and Ms. Geetha Manjunath, Founder & CEO, Niramai Analytics.

The third plenary session will be held on Promoting Holistic Healthcare, and this session will bring together global healthcare experts and AYUSH experts to discuss the shift towards holistic healthcare. The session will be chaired and moderated by Vaidya Rajesh Kotecha, Secretary, AYUSH, Government of India. Speakers for this session included Ms. Phyllis Kim, Senior Health Specialist, World Bank, Ms. Neelam Makhijani, Country Director of Management Sciences for Health, Vaidya CV Jayadevan, Principal, VPSC Ayurveda College, Kerala, and Vaidya Prof. Rajeev Vasudevan, MD & CEO, Apollo Ayurveda Hospital.

Over the past two decades, during the Vibrant Gujarat journey that began in 2003, the state's public healthcare infrastructure has grown by 30%. This robust system is further supported by a very strong private medical and healthcare sector. Specialist care in the public sector has improved tremendously with the establishment of 40 medical college hospitals (from only 12 in 2003), 6900 medical seats (previously 1525), a 25-fold increase in dialysis units and a three-fold increase in chemotherapy centres. This has resulted in over 60% reduction in infant and maternal mortality.

Along with this, since the year 2003, the state has also seen a 2.5-fold increase in pharmaceuticals manufacturing and selling units and a 9-fold increase in USFDA approved units, thereby increasing Gujarat's share of pharma export business by 3-fold. With an estimated turnover of ₹1,46,606 crore and an increase of 8.4 times over the 2003 estimate, the state is de facto recognized as the pharma capital of the nation.

The state of Gujarat not only offers world-class healthcare services, but also has strong allied sectors, such as AYUSH and wellness, thriving pharmaceutical, diagnostics and medical devices sectors, rehabilitation services and a focus on medical research and development (Medical R&D). is coming. All these together ensure that the healthcare ecosystem is holistic and complete.

Also Read: Prime Minister Narendra Modi unveils ambitious developmental projects during Lakshadweep visit

OTT India updates you with the latest news, Country’s no.1 digital news platform OTT India, Keeps you updated with national, and international news from all around the world. For more such updates, download the OTT India app on your Android and IOS device.

Tags :
Aakash KhumanAllied sectorsAPI and production linked incentive schemesAYUSHBulk drug and medical devices parksC-DAC Medtronics IndiaCabinet Minister Rushikeshbhai PatelChief Minister Bhupendrabhai PatelDepartment of Health and Family WelfareGandhinagarGujarat government officialsgujarat newsHealthcare infrastructureHolistic HealthcareInstemManagement Sciences for HealthMedical college hospitalsMedical devicesMedical R&DMedical research and developmentnewsNiramai AnalyticsOTT IndiaPharma capital of the nationPharma export businessPharmaceutical sectorPlenary sessionsRehabilitation servicesTechnology in healthcareTechnology transformationThe Leela HotelUniversal healthcareUS FDAvibrant gujarat global summitWorld BankZydus Life Sciences
Next Article